TB-500 Dosing Protocol: Research-Based Guidelines

Also known as: Thymosin Beta-4, Tβ4

recovery

Research Reference Only

This information is for educational purposes only. TB-500 is not FDA approved for human use. The protocols listed are summaries of published research studies and do not constitute medical advice. Always consult a licensed healthcare provider.

Overview

TB-500 is the synthetic version of Thymosin Beta-4, a naturally occurring peptide present in virtually all human and animal cells. Research has focused on its role in actin regulation and tissue regeneration.

Mechanisms of Action

Regulates actin polymerization

Promotes cell migration

Modulates inflammatory responses

Supports stem cell differentiation

Research Protocols

The following protocols are summaries of published research studies. They are presented for educational purposes only and do not constitute medical advice.

Protocol Name	Source	Dose	Frequency	Duration	Route	Evidence	Link
Wound Healing Study	published study	6 mg	Weekly	6 weeks	Subcutaneous	animal

Important Warnings

Safety Considerations

Research use only
Limited human safety data